phosphorus has been researched along with ferric oxide, saccharated in 20 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (ferric oxide, saccharated) | Trials (ferric oxide, saccharated) | Recent Studies (post-2010) (ferric oxide, saccharated) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 690 | 193 | 341 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 8 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imamura, K | 1 |
| Iida, M; Imamura, K; Okada, M; Okuda, S; Oochi, N; Sanai, T | 1 |
| Fukumoto, S; Mori, H; Okada, Y; Tanaka, Y; Yamamoto, S | 1 |
| Chong, EM; Covic, AC; Floege, J; Gaillard, S; Ketteler, M; Lisk, LJ; Mann, JF; Rastogi, A; Spinowitz, B; Sprague, SM | 1 |
| Akizawa, T; Fukagawa, M; Koiwa, F; Terao, A; Yokoyama, K | 1 |
| Akizawa, T; Fukagawa, M; Koiwa, F; Yokoyama, K | 1 |
| Anderson, L; Coyne, DW; Ficociello, LH; Kossmann, RJ; Maddux, FW; Mullon, C; Ofsthun, NJ; Parameswaran, V; Sprague, SM; Vemula, S | 1 |
| Hayashi, H; Ichie, T; Sugiura, Y; Sugiyama, T; Suzuki, D | 1 |
| Anderson, L; Coyne, DW; Ficociello, LH; Kalantar-Zadeh, K; Kossmann, RJ; Kwoh, C; Mullon, C; Ofsthun, NJ; Parameswaran, V | 1 |
| Covic, AC; Floege, J; Ketteler, M; Rakov, V; Rastogi, A; Spinowitz, B; Sprague, SM; Walpen, S | 1 |
| Davis, S; Ficociello, LH; Kalantar-Zadeh, K; Kendrick, J; Kossmann, RJ; Mullon, C; Ofsthun, NJ; Parameswaran, V | 1 |
| Athienites, NV; Coyne, DW; Ficociello, LH; Kalantar-Zadeh, K; Kossmann, RJ; Mullon, C; Parameswaran, V | 1 |
| Covic, AC; Floege, J; Ketteler, M; Perrin, A; Rastogi, A; Sprague, SM; Walpen, S | 1 |
| Behets, GJ; Corremans, R; D'Haese, PC; Funk, F; Neven, E; Verhulst, A; Vervaet, BA; Walpen, S | 1 |
| Abitbol, CL; Ahn, SY; Balgradean, M; Enoiu, M; Fathallah-Shaykh, S; Fila, M; Greenbaum, LA; Jankauskiene, A; Jeck, N; Klaus, G; Nelson, R; Paredes, A; Perrin, A; Stoica, C; Swinford, RD; Wickman, L | 1 |
| Coyne, DW; Kalantar-Zadeh, K; Ramos, R; Sprague, SM; Vervloet, M | 1 |
| Allen, MR; Avin, KG; Biruete, A; Chen, NX; Clinkenbeard, EL; Metzger, CE; Moe, SM; O'Neill, K; Srinivasan, S; Stacy, AJ; Swallow, EA; Vrabec, C | 1 |
| Fujibayashi, A; Kawabata, H; Sugimura, M; Tamai, S; Tamura, T | 1 |
| Andrews, ES; Kendrick, J; Perez, L; Ramirez-Renteria, L; Reddin, R; Teitelbaum, I; Wilson, G; You, Z | 1 |
| Anger, MS; Ficociello, LH; Mullon, C; Rhee, CM; Woznick, R; Zhou, M | 1 |
1 review(s) available for phosphorus and ferric oxide, saccharated
| Article | Year |
|---|---|
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence.
Topics: Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Phosphates; Phosphorus; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis; Retrospective Studies; Sucrose | 2022 |
7 trial(s) available for phosphorus and ferric oxide, saccharated
| Article | Year |
|---|---|
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
Topics: Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Male; Middle Aged; Phosphorus; Prognosis; Renal Dialysis; Sucrose; Time Factors | 2015 |
Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.
Topics: Administration, Oral; Aged; Biomarkers; Calcium; Chelating Agents; Drug Administration Schedule; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sucrose; Tablets; Time Factors; Treatment Outcome | 2017 |
Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study.
Topics: Aged; Asian People; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sucrose; Treatment Outcome | 2017 |
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Topics: Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Ferric Compounds; Fibroblast Growth Factor-23; Follow-Up Studies; Humans; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sevelamer; Sucrose; Time Factors; Treatment Outcome | 2019 |
Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.
Topics: Adult; Age Factors; Aged; Calcimimetic Agents; Chelating Agents; Drug Combinations; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sucrose; Vitamin D | 2020 |
Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease.
Topics: Adolescent; Child; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sucrose | 2021 |
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Hemoglobins; Humans; Hypophosphatemia; Iron; Iron Deficiencies; Menorrhagia; Phosphorus | 2022 |
12 other study(ies) available for phosphorus and ferric oxide, saccharated
| Article | Year |
|---|---|
Effects of intravenous administration of iron preparations on the metabolism of phosphorus. Comparative study on 3 iron preparations.
Topics: Adult; Aged; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Tubules; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 1984 |
Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats.
Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Creatinine; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Iron-Dextran Complex; Kidney; Male; Organ Size; Phosphorus; Rats; Rats, Sprague-Dawley; Serum Albumin; Sodium | 2005 |
Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
Topics: Absorptiometry, Photon; Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Osteomalacia; Phosphorus; Time Factors; Treatment Outcome; Withholding Treatment | 2012 |
Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data
.
Topics: Adult; Aged; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Retrospective Studies; Sucrose | 2017 |
Efficacy of sucroferric oxyhydroxide treatment in Japanese hemodialysis patients and its effect on gastrointestinal symptoms.
Topics: Aged; Chelating Agents; Constipation; Diarrhea; Drug Combinations; Drug Therapy, Combination; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Male; Middle Aged; Phosphorus; Renal Dialysis; Sucrose; Time Factors | 2017 |
Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.
Topics: Adult; Aged; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Retrospective Studies; Sucrose | 2018 |
One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis.
Topics: Adult; Aged; Chelating Agents; Cohort Studies; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Male; Medication Adherence; Middle Aged; Nutritional Status; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency; Sucrose; Time Factors; Treatment Outcome | 2019 |
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study.
Topics: Cohort Studies; Creatinine; Dietary Proteins; Drug Combinations; Drug Substitution; Female; Ferric Compounds; Humans; Hypoalbuminemia; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Serum Albumin; Sucrose | 2019 |
Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.
Topics: Animals; Disease Models, Animal; Drug Combinations; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Kidney Failure, Chronic; Male; Phosphorus; Rats; Rats, Wistar; Sucrose; Vascular Calcification | 2020 |
Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
Topics: Animals; Biomarkers; Chronic Kidney Disease-Mineral and Bone Disorder; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factors; Homeostasis; Iron; Male; Minerals; Parathyroid Hormone; Phosphorus; Rats; Renal Insufficiency, Chronic; Transferrins | 2022 |
A 6-Month clinical practice pilot study of sucroferric oxyhydroxide on nutritional status in patients on peritoneal dialysis.
Topics: Adult; Aged; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Hypoalbuminemia; Middle Aged; Nutritional Status; Peritoneal Dialysis; Phosphates; Phosphorus; Pilot Projects; Prospective Studies; Serum Albumin; Sucrose | 2022 |
A real-world analysis of the influence of age on maintenance hemodialysis patients: managing serum phosphorus with sucroferric oxyhydroxide as part of routine clinical care.
Topics: Adult; Aged; Drug Combinations; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Retrospective Studies | 2023 |